SCHEMBL8552074

SCHEMBL8552074

NCCC#CCCc1ccccc1.O=C1c2ccccc2C(=O)N1CCC#CCCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
CASP3 P42574 1/20 0.54
ALDH1A1 P00352 3/20 0.48
GAA P10253 2/20 0.48
MAPT P10636 2/20 0.48
RAB9A P51151 2/20 0.48
KDM4E B2RXH2 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA9 Q16790 1/20 0.46
MAOB P27338 1/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43
APAF1 O14727 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8549922 0.93 CASP3 (0.61) TDP1L3MBTL1CASP3ALDH1A1GAA
SCHEMBL8556103 0.82 TDP1 (0.50) TDP1L3MBTL1CASP3ALDH1A1GAA
SCHEMBL8556105 0.82 TDP1 (0.50) TDP1L3MBTL1CASP3ALDH1A1GAA
SCHEMBL8556531 0.79 HTR2A (0.58) ALDH1A1RAB9ASMN1; SMN2TSHRMAOB
SCHEMBL29724090 0.76 CASP3 (0.86) TDP1L3MBTL1CASP3ALDH1A1GAA
SCHEMBL1142116 0.76 CASP3 (0.86) TDP1L3MBTL1CASP3ALDH1A1GAA
SCHEMBL11758524 0.75 TDP1 (0.53) TDP1L3MBTL1MAPTRAB9ASMN1; SMN2
SCHEMBL30371663 0.73 TDP1 (0.86) TDP1L3MBTL1CASP3ALDH1A1GAA
SCHEMBL45050 0.73 TDP1 (0.86) TDP1L3MBTL1CASP3ALDH1A1GAA
SCHEMBL6122839 0.72 RAB9A (0.50) TDP1L3MBTL1CASP3MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0840725-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-05-13 EP disclosed